Catherine Weiss, PhD

Efficacy of Adjunctive Brexpiprazole in Major Depressive Disorder: A Pooled Response Quartile Analysis

Background: We assessed varying levels of response to brexpiprazole adjunctive to standard antidepressant therapy (ADT).

Catherine Weiss , PhD;

Stine Rasmussen Meehan , PhD;

Mary Hobart , PhD;

Dalei Chen , PhD;

11/22/2019

Predictors of Weight Change After Long-Term Treatment With Brexpiprazole in Schizophrenia

Background: We assessed effects contributing to weight gain during long-term treatment with brexpiprazole.

Mette Josiassen , PhD;

Anders Tvistholm , MS;

Catherine Weiss , PhD;

Stine Rasmussen Meehan , PhD;

Mary Hobart , PhD;

Ross Baker , PhD, MBA;

11/22/2019

Exploring Patient Experiences Taking Adjunctive Brexpiprazole for Major Depressive Disorder (MDD): Post-hoc Analysis of Exit Interview Data

Background: The efficacy and safety of adjunctive brexpiprazole, a serotonin–dopamine activity modulator, has been demonstrated in clinical studies in adults with MDD and inadequate respo...

Michelle Brown , PhD;

Catherine Gupta , PhD;

Dana DiBenedetti , PhD;

Michael Thase , MD;

Zahinoor Ismail , MD;

Roger McIntyre , MD, FRCPC;

Catherine Weiss , PhD;

Stine Rasmussen Meehan , PhD;

H. Lundbeck ;

11/22/2019

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Catherine Weiss, PhD

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products